Gufic BioSciences Ltd Faces Bearish Momentum Amid Technical Indicator Shifts

Technical Momentum and Price Action Overview

Gufic BioSciences currently trades at ₹336.75, down from the previous close of ₹340.00, marking a daily decline of 0.96%. The stock’s intraday range has been relatively narrow, with a low of ₹335.60 and a high of ₹341.20. Over the past 52 weeks, the share price has fluctuated between ₹285.00 and ₹497.75, indicating significant volatility within the year.

While the stock recorded a slight weekly return of 0.87%, marginally outperforming the Sensex’s 0.85% gain, the monthly and yearly returns tell a different story. Gufic’s one-month return stands at -3.11%, contrasting with the Sensex’s positive 0.73%. More strikingly, the stock has underperformed over the past year with a -27.29% return, whereas the Sensex has appreciated by 7.28% during the same period.

Shift in Technical Trend: From Mildly Bearish to Bearish

MarketsMOJO’s technical analysis reveals a clear shift in Gufic BioSciences’ trend from mildly bearish to outright bearish. This deterioration is reflected across multiple timeframes and indicators, signalling increased downside risk for investors.

The daily moving averages have turned bearish, indicating that short-term price momentum is weakening. The weekly and monthly KST (Know Sure Thing) indicators also confirm bearish momentum, with the weekly KST firmly bearish and the monthly KST mildly bearish. This suggests that both intermediate and longer-term momentum are under pressure.

MACD and RSI: Mixed Signals but Leaning Bearish

The Moving Average Convergence Divergence (MACD) indicator presents a nuanced picture. On a weekly basis, the MACD remains mildly bullish, suggesting some short-term positive momentum. However, the monthly MACD has turned mildly bearish, indicating that longer-term momentum is weakening. This divergence between weekly and monthly MACD readings highlights the stock’s struggle to sustain upward momentum over extended periods.

The Relative Strength Index (RSI), a momentum oscillator, currently shows no clear signal on both weekly and monthly charts. This neutral RSI reading suggests that the stock is neither overbought nor oversold, but combined with other bearish indicators, it implies limited upside potential in the near term.

Bollinger Bands and On-Balance Volume Confirm Bearish Bias

Bollinger Bands on both weekly and monthly charts are mildly bearish, signalling that price volatility is skewed towards the downside. The stock price is closer to the lower band, which often indicates selling pressure.

On-Balance Volume (OBV) analysis on the weekly timeframe is mildly bearish, reflecting that volume trends are not supporting price advances. The monthly OBV shows no clear trend, further underscoring the lack of strong buying interest over the longer term.

Dow Theory and Moving Averages: Weakening Trend Confirmation

According to Dow Theory, the weekly trend is mildly bearish, while the monthly trend shows no definitive direction. This suggests that while short-term price action is negative, the longer-term trend remains uncertain but lacks bullish confirmation.

Daily moving averages have decisively turned bearish, reinforcing the short-term downtrend. This is a critical signal for traders and investors, as moving averages often act as dynamic support and resistance levels.

Market Capitalisation and Mojo Score Implications

Gufic BioSciences holds a Market Cap Grade of 3, indicating a mid-tier market capitalisation relative to its peers. Its Mojo Score has declined to 23.0, with the Mojo Grade downgraded from Sell to Strong Sell on 17 Nov 2025. This downgrade reflects the deteriorating technical and fundamental outlook for the stock.

Despite the negative near-term signals, Gufic’s long-term returns remain impressive. Over the past five and ten years, the stock has delivered returns of 176.82% and 507.85% respectively, significantly outperforming the Sensex’s 79.16% and 227.83% returns over the same periods. This long-term outperformance highlights the company’s underlying growth potential, though current technicals suggest caution.

Investor Takeaway: Navigating the Bearish Technical Landscape

Investors in Gufic BioSciences should approach the stock with caution given the prevailing bearish technical signals. The downgrade to Strong Sell by MarketsMOJO reflects the consensus that the stock’s momentum is weakening across multiple timeframes and indicators.

Short-term traders may find limited opportunities given the bearish daily moving averages and weekly KST, while longer-term investors should monitor monthly MACD and Bollinger Bands for signs of trend reversal. The neutral RSI readings suggest that the stock is not yet oversold, implying further downside risk before a potential recovery.

Comparing Gufic’s performance with the broader market, the stock’s underperformance over the past year contrasts with its strong long-term returns, highlighting the importance of timing and technical analysis in managing exposure.

Overall, the technical landscape suggests that Gufic BioSciences is currently in a consolidation or correction phase, with bearish momentum dominating. Investors should weigh these signals carefully against their risk tolerance and investment horizon.

Summary of Key Technical Indicators for Gufic BioSciences Ltd

• Daily Moving Averages: Bearish


• Weekly MACD: Mildly Bullish


• Monthly MACD: Mildly Bearish


• Weekly RSI: No Signal


• Monthly RSI: No Signal


• Weekly Bollinger Bands: Mildly Bearish


• Monthly Bollinger Bands: Mildly Bearish


• Weekly KST: Bearish


• Monthly KST: Mildly Bearish


• Weekly Dow Theory: Mildly Bearish


• Monthly Dow Theory: No Trend


• Weekly OBV: Mildly Bearish


• Monthly OBV: No Trend

Given these signals, the stock’s technical trend has clearly shifted towards a bearish stance, warranting a cautious approach from market participants.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Saving Now →